Phosphagenics Limited

ASX:POH ISIN:AU000000POH7

Phosphagenics is a Melbourne-based, globally driven biotechnology company focused on the discovery of new and cost effective ways to enhance the bioavailability, activity, safety and delivery of proven pharmaceutical and nutraceutical products.

Phosphagenics' core technology is built around the science and application of phosphorylation, a process where the addition of a phosphate group has been found to enhance the bioavailability, activity and safety of existing pharmaceuticals and nutraceuticals, as well as to assist in the production of drug delivery platforms.

Phosphagenics' shares are listed on the Australian Stock Exchange (POH) and the London Stock Exchange's Alternative Investment Market (PSG). An ADR - Level 1 program was established in the U.S. with The Bank of New York Mellon (PPGNY) for U.S. investors to trade in Phosphagenics' stock on the 'over-the-counter' market. In July 2007, this was upgraded to the International OTCQX, a new premium market tier in the U.S. for international exchange-listed companies, operated by Pink Sheets, LLC. 
 
          

Sprache wählen

News

Australischer Marktbericht, 7. Februar 2011: Automotive Technology Group (ASX:ATJ) kündigt den effizientesten Supercharger der Welt an

🕔2/7/2011 1:30:00 PM 11711

Australischer Marktbericht, 7. Februar 2011 beinhaltet: Automotive Technology Group Limited (ASX:ATJ) verlautbart, dass der Sprintex (R) Supercharger das weltweit effizienteste Supercharger-System ist; Kohle-Studie bestätigt das Potential für Export-Grade Kraftwerkskohle aus dem Aviva Corporation Limited (ASX:AVA) Mmamantswe Projekt in Botswana; EnviroGold Limited (ASX:EVG) hat sein Management in Lateinamerika deutlich gestärkt; Phosphagenics Limited (ASX:POH) kündigt Kollaboration an, um ein Medikament für die Behandlung von Psoriasis in den USA zu entwickeln.

Lesen Sie die komplette Artikel
###

84,329 COMPANY PROFILE VIEWS

  • Diese Seite wurde besucht: (letzten 7 Tagen: 10) (letzten 30 Tagen: 49) (seit Veröffentlichung: 6985) 

Company Data

    Fax
  • 03 9605 5999 
  • Principal Sector
  • Gesundheit & Pharm 
  • Principal Industry
  • Biotechnology 
  • Homepage
  • www.phosphagenics.com

More News Results

  • 2024/02/20: General Security Deed*
  • 2024/02/20: Series Notice*
  • 2024/02/20: Notice of Creation of Trust*
  • 2024/02/20: Deed of Amendment*
  • 2024/02/20: Master Definition Schedule*
  • 2024/02/20: Master Security Trust Deed Amending Deed*
  • 2024/02/20: Master Trust Deed Amending Deed*
  • 2024/02/20: Information Memorandum*
  • 2024/02/20: Information Form and Checklist*
  • 2024/02/20: Appendix 1B*
*refer to company website